News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
590,870 Results
Type
Article (42591)
Company Profile (346)
Press Release (547933)
Section
Business (167483)
Career Advice (2455)
Deals (30307)
Drug Delivery (103)
Drug Development (78633)
Employer Resources (148)
FDA (14367)
Job Trends (12958)
News (295817)
Policy (28582)
Tag
Academia (2660)
Alliances (42864)
Alzheimer's disease (1348)
Approvals (14315)
Artificial intelligence (169)
Bankruptcy (318)
Best Places to Work (10648)
Biotechnology (276)
Breast cancer (204)
Cancer (1554)
Cardiovascular disease (133)
Career advice (2061)
CAR-T (114)
Cell therapy (330)
Clinical research (62875)
Collaboration (579)
Compensation (231)
COVID-19 (2534)
C-suite (146)
Data (1486)
Diabetes (189)
Diagnostics (5674)
Earnings (60427)
Employer resources (136)
Events (88382)
Executive appointments (501)
FDA (15119)
Funding (519)
Gene therapy (236)
GLP-1 (658)
Government (4195)
Healthcare (17195)
Infectious disease (2631)
Inflammatory bowel disease (124)
Interviews (524)
IPO (14150)
Job creations (2742)
Job search strategy (1692)
Layoffs (416)
Legal (6043)
Lung cancer (240)
Manufacturing (205)
Medical device (11032)
Medtech (11036)
Mergers & acquisitions (16406)
Metabolic disorders (517)
Neuroscience (1745)
NextGen: Class of 2025 (5947)
Non-profit (4127)
Northern California (1742)
Obesity (289)
Opinion (218)
Patents (132)
People (53418)
Phase I (19727)
Phase II (27771)
Phase III (20685)
Pipeline (617)
Postmarket research (2394)
Preclinical (8315)
Radiopharmaceuticals (249)
Rare diseases (308)
Real estate (4489)
Regulatory (19927)
Research institute (2267)
Resumes & cover letters (361)
Southern California (1571)
Startups (3170)
United States (15492)
Vaccines (557)
Weight loss (214)
Date
Today (154)
Last 7 days (454)
Last 30 days (1920)
Last 365 days (33150)
2025 (1816)
2024 (33583)
2023 (37504)
2022 (48407)
2021 (52035)
2020 (50009)
2019 (42513)
2018 (32046)
2017 (29623)
2016 (28219)
2015 (32950)
2014 (25391)
2013 (20578)
2012 (21802)
2011 (22728)
2010 (20440)
Location
Africa (743)
Arizona (146)
Asia (36020)
Australia (7166)
California (4036)
Canada (1487)
China (347)
Colorado (180)
Connecticut (180)
Europe (80608)
Florida (564)
Georgia (130)
Illinois (375)
Indiana (216)
Maryland (662)
Massachusetts (3041)
Michigan (171)
Minnesota (275)
New Jersey (1133)
New York (1135)
North Carolina (751)
Northern California (1742)
Ohio (135)
Pennsylvania (886)
South America (1019)
Southern California (1571)
Texas (567)
Utah (121)
Washington State (398)
590,870 Results for "cascadian therapeutics formally known as oncothyreon".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Gilead Continues Diversification Drive With Potential $1.7B Inflammation Pact With LEO
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 and IL-13 signaling, which in turn are known inflammatory targets.
January 13, 2025
·
2 min read
·
Tristan Manalac
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Business
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
Chromocell Therapeutics Corp. today announced that it has formally launched its eye pain treatment program with the hiring of Dr. Simon Chandler.
March 21, 2024
·
5 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner
Perseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of inflammatory diseases, including asthma.
May 22, 2024
·
2 min read
Editorial
Sarepta, Biotech’s Regulatory Go-Getter, Signs Standout Rare Disease Deal
Not exactly known for its dealmaking, Sarepta Therapeutics has thrown down a massive wad of cash to work with Arrowhead Pharmaceuticals on RNAi-based medicines.
December 4, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
New SELECT trial analysis with semaglutide 2.4 mg showed a significant reduction in hospital admissions in adults with known heart disease and obesity or overweight
November 4, 2024
·
6 min read
Business
Medivir’s partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701
Medivir AB announced today that its partner Vetbiolix, a veterinary biotechnology company based in France , reported positive results from a Proof-of-Concept clinical study in periodontal disease in dog with its drug candidate VBX-1000, previously known as MIV-701.
April 15, 2024
·
3 min read
Press Releases
The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer
August 13, 2024
·
5 min read
Press Releases
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 13, 2025
·
9 min read
1 of 59,087
Next
